Posted by Michael Wonder on 24 Mar 2022
Moderna finalises strategic partnership with Australian Government
23 March 2022 - On-shore manufacturing facility based in Melbourne, Australia, expected to produce up to 100 million mRNA respiratory vaccine doses annually.
Moderna, today announced the finalisation of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility in Australia.
This finalises the agreement in principle with the Australian Federal Government announced in December 2021.
